Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Analytical Toxicology

• Publication date

  2015-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/jat/bkv045PMID 25957385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.

  2015cited by this paper
• Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.

  2015cited by this paper
• High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.

  2015cited by this paper
• Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.

  2014cited by this paper
• Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.

  2014cited by this paper
• Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS.

  2014cited by this paper
• “Spice,” “Kryptonite,” “Black Mamba”: An Overview of Brand Names and Marketing Strategies of Novel Psychoactive Substances on the Web

  2014cited by this paper
• NMR Assignment of N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide Seized as Herbal Incense for the First Time in Italy

  2014cited by this paper
• LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine

  2014cited by this paper
• UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.

  2014cited by this paper
• Ballistics examination of air rifle.

  2014cited by this paper
• Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry

  2014cited by this paper
• Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine.

  2013cited by this paper
• Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product.

  2013cited by this paper
• The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography - mass spectrometry.

  2013cited by this paper
• First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry

  2013cited by this paper
• Characterization of In Vitro Metabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC‐MS/MS

  2013cited by this paper
• First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.

  2013cited by this paper
• Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS.

  2013cited by this paper
• In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200.

  2013cited by this paper
• Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.

  2013cited by this paper
• Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS.

  2012cited by this paper
• Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.

  2012cited by this paper
• Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in

  2012cited by this paper
• The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry.

  2012cited by this paper
• The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry.

  2012cited by this paper
• Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

  2012cited by this paper
• Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.

  2012cited by this paper
• Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.

  2011cited by this paper
• Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.

  2011cited by this paper
• Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites.

  2011cited by this paper
• Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures.

  2011cited by this paper
• Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures.

  2011cited by this paper
• Detection of JWH-018 metabolites in smoking mixture post-administration urine.

  2010cited by this paper

• Drug target residue selection for synthetic cannabinoids monitoring by wastewater-based epidemiology: case study of the AKB-48F (4F-ABINACA or 4F-ABUTINACA)

  2025influential citation
• Sex‐specific behavioural, metabolic, and immunohistochemical changes after repeated administration of the synthetic cannabinoid AKB48 in mice

  2023cites this paper
• In vitro metabolic profiling of new synthetic cannabinoids, ADB-FUBIATA, AFUBIATA, CH-FUBIATA, and CH-PIATA

  2023cites this paper
• The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC–QTOF-MS and synthesized reference standards

  2023cites this paper
• Identification of Cytochrome P450 Enzymes Responsible for Oxidative Metabolism of Synthetic Cannabinoid (1-Hexyl-1H-Indol-3-yl)-1-naphthalenyl-methanone (JWH-019)

  2023cites this paper
• Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes

  2022cites this paper
• Comparison between human liver microsomes and the fungus Cunninghamella elegans for biotransformation of the synthetic cannabinoid JWH-424 having a bromo-naphthyl moiety analysed by high-resolution mass spectrometry

  2022cites this paper
• Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine and Blood Samples

  2021cites this paper
• Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs

  2021cites this paper
• Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.

  2020influential citation
• Synthesis of nine potential synthetic cannabinoid metabolites with a 5F-4OH pentyl side chain from a scalable key intermediate

  2020cites this paper
• Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative Kinetics

  2020influential citation
• Study of the in vitro and in vivo metabolism of a novel synthetic cannabinoid PX-2 in human liver microsomes and zebrafish

  2020cites this paper
• Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite

  2020cites this paper
• Can X-Ray Powder Diffraction Be a Suitable Forensic Method for Illicit Drug Identification?

  2020cites this paper
• In vitro metabolic profiles of adamantyl positional isomers of synthetic cannabinoids

  2020cites this paper
• In vitro phase I metabolic profiling of the synthetic cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC and AMB-FUBINACA.

  2020cites this paper
• In vivo and in vitro metabolism of the novel synthetic cannabinoid 5F-APINAC

  2019cites this paper
• Review of Synthetic Cannabinoids on the Illicit Drug Market

  2019cites this paper
• Toxic lifespan of the synthetic opioid U-47,700 in Finland verified by re-analysis of UPLC-TOF-MS data.

  2019cites this paper
• Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.

  2019cites this paper
• In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters

  2019cites this paper
• Pharmacological and Behavioral Effects of the Synthetic Cannabinoid AKB48 in Rats

  2019cites this paper
• Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes

  2018cites this paper
• Synthetic cannabinoids: Variety is definitely not the spice of life.

  2018cites this paper
• Metabolic Study of New Psychoactive Substances by Shimpei Watanabe

  2018influential citation
• Synthesis and identifications of potential metabolites as biomarkers of the synthetic cannabinoid AKB-48

  2018cites this paper
• Metabolism of the synthetic cannabinoids AMB-CHMICA and 5C-AKB48 in pooled human hepatocytes and rat hepatocytes analyzed by UHPLC-(IMS)-HR-MSE.

  2018cites this paper
• Using Ion Mobility to separate different designer drug metabolites

  2018cites this paper
• Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC–QTOF–MS

  2018cites this paper
• In vivo metabolism of the new synthetic cannabinoid APINAC in rats by GC–MS and LC–QTOF-MS

  2017cites this paper
• Pharmaco‐toxicological effects of the novel third‐generation fluorinate synthetic cannabinoids, 5F‐ADBINACA, AB‐FUBINACA, and STS‐135 in mice. In vitro and in vivo studies

  2017influential citation
• Metabolic and pharmacokinetic characterization of a new synthetic cannabinoid APINAC in rats

  2017cites this paper
• Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans

  2017cites this paper
• Variation in commercial smoking mixtures containing third-generation synthetic cannabinoids.

  2017cites this paper
• Synthesis and identification of an important metabolite of AKB-48 with a secondary hydroxyl group on the adamantyl ring

  2017cites this paper
• Procedure for setting control for the turnover of new, potentially hazardous psychoactive substances. Detection of metabolites of a new APINAC psychoactive compound in rat urine by gas and liquid chromatography with mass spectrometry detection

  2017cites this paper
• Application of high-performance liquid chromatography with charged aerosol detection (LC–CAD) for unified quantification of synthetic cannabinoids in herbal blends and comparison with quantitative NMR results

  2017cites this paper
• In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201)

  2016cites this paper
• Identification of new synthetic cannabinoid analogue APINAC (adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate) with other synthetic cannabinoid MDMB(N)-Bz-F in illegal products

  2016cites this paper
• New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics

  2016cites this paper
• Chromatographic analysis and survey studies to evaluate the emerging drugs of synthetic cannabinoids in Scotland and Saudi Arabia

  2016cites this paper
• Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.

  2016cites this paper
• Tentative identification of in vitro metabolites of 5-APDB, a synthetic benzofuran, by LC-Q/TOF-MS.

  2016cites this paper
• JWH-018 ω-OH, a shared hydroxy metabolite of the two synthetic cannabinoids JWH-018 and AM-2201, undergoes oxidation by alcohol dehydrogenase and aldehyde dehydrogenase enzymes in vitro forming the carboxylic acid metabolite.

  2016cites this paper
• Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies

  2016cites this paper
• How present synthetic cannabinoids can help predict symptoms in the future

  2016cites this paper